未登录 分享 收藏
Temsirolimus (T) in patients (pts) with solid tumors with AKT1/3 amplification (amp) or mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study 患有AKT1/3扩增 (amp) 或突变 (mut) 的实体瘤患者 (pts) 的替西罗莫司 (T): 靶向药物和分析利用注册中心 (TAPUR) 研究的结果 Behl, Deepti; Rothe, Michael; Mangat, Pam K.; Garrett-Mayer, Elizabeth; Mackler, Niklas; Duvivier, Herbert L.; Gold, Philip J.; Patel, Sapna R.; Duffy, Regan M.; Mauro, Lauren A.; Ahn, Eugene R.; Bell, Maria; Calfa, Carmen J.; Grem, Jean L.; Rueter, Jens; von Mehren, Margaret; Grantham, Gina N.; Gregory, Abigail; Hinshaw, Dominique C.; Halabi, Susan; Schilsky, Richard L. 分享 收藏
First-in-human, dose escalation and expansion study of MT-6402, a novel engineered toxin body (ETB) targeting PD-L1, in patients with PD-L1 expressing relapsed/refractory advanced solid tumors: Interim data Van Tine, Brian A.; Ahn, Eugene; Redman, Rebecca A.; Barve, Minal A.; Edenfield, William J.; Peguero, Julio; Villaflor, Victoria M.; Rasco, Drew W.; Powell, Steven F.; Mamuye, Admasu T.; Moore, Chris B.; Pelham, Joshua M.; Charoenthongtrakul, Soratree; Spigel, David R. 分享 收藏
Palbociclib (P) in patients (pts) with solid tumors with CDK4 or CDK6 amplification (amp): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study Khalil, M. F.; Rothe, M.; Mangat, P. K.; Garrett-Mayer, E.; Mileham, K. F.; Ahn, E. R.; Duvivier, H. L.; Farrington, L. C.; Akce, M.; Behl, D.; Gold, P. J.; Chiu, V. K.; Vijayvergia, N.; Calfa, C.; Gaba, A.; Meric-Bernstam, F.; Schuetze, S. M.; Gregory, A.; Halabi, S.; Schilsky, R. L. 分享 收藏
分享 收藏
Crizotinib (C) in patients (pts) with solid tumors with MET amplification (amp) or mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study Mileham, Kathryn F.; Rothe, Michael; Mangat, Pam K.; Garrett-Mayer, Elizabeth; Duvivier, Herbert L.; Calfa, Carmen J.; Dul, Carrie L.; Marr, Alissa S.; Ahn, Eugene R.; Behl, Deepti; Hall, Michael J.; Mehmi, Inderjit; Gaba, Anu; Leidner, Rom; Zalupski, Mark M.; Grantham, Gina N.; Gregory, Abigail; Halabi, Susan; Schilsky, Richard L. 分享 收藏
Effect of treatment center volume on outcomes in gastroenteropancreatic neuroendocrine tumor patients Baeg, Kiwoon; Harris, Cynthia; Naparst, Monica S.; Ahn, Eugene; Thapi, Sahityasri; Martin, Jacob; Rustgi, Sheila; Mhango, Grace; Wisnivesky, Juan; Kim, Michelle Kang 分享 收藏
Efficacy, safety, and quality of life (QoL) with futibatinib in patients (pts) with intrahepatic cholangiocarcinoma (iCCA) harboring FGFR2 fusions/rearrangements: FOENIX-CCA2 Furuse, J.; Goyal, L.; Meric-Bernstam, F.; Hollebecque, A.; Valle, J. W.; Morizane, C.; Karasic, T. B.; Abrams, T. A.; Kelley, R. K.; Cassier, P. A.; Klumpen, H-J.; Uboha, N.; Mahipal, A.; Mitchell, E.; Ahn, E.; Chang, H-M.; Masuda, K.; He, Y.; Benhadji, K. A.; Bridgewater, J. A. 分享 收藏
Sunitinib in Patients with Metastatic Colorectal Cancer (mCRC) withFLT-3Amplification: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study Al Baghdadi, Tareq; Garrett-Mayer, Elizabeth; Halabi, Susan; Mangat, Pam K.; Rich, Patricia; Ahn, Eugene R.; Chai, Seungjean; Rygiel, Andrew L.; Osayameh, Olufunlayo; Antonelli, Kaitlyn R.; Islam, Samiha; Bruinooge, Suanna S.; Schilsky, Richard L. 分享 收藏
Efficacy and safety of futibatinib in intrahepatic cholangiocarcinoma (iCCA) harboring FGFR2 fusions/other rearrangements: Subgroup analyses of a phase II study (FOENIX-CCA2) Bridgewater, J.; Meric-Bernstam, F.; Hollebecque, A.; Valle, J. W.; Morizane, C.; Karasic, T.; Abrams, T.; Furuse, J.; Kelley, R. K.; Cassier, P.; Klumpen, H-J.; Uboha, N.; Mahipal, A.; Mitchell, E.; Ahn, E. R.; Chang, H-M.; Masuda, K.; He, Y.; Benhadji, K.; Goyal, L. 分享 收藏
分享 收藏
Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE) Kundranda, M.; Gracian, A. C.; Zafar, S. F.; Meiri, E.; Bendell, J.; Alguel, H.; Rivera, F.; Ahn, E. R.; Watkins, D.; Pelzer, U.; Charu, V; Zalutskaya, A.; Kuesters, G.; Pipas, J. M.; Santillana, S.; Askoxylakis, V; Ko, A. H. 分享 收藏
Sunitinib (S) in patients (Pts) with metastatic colorectal cancer (mCRC) with FLT-3 alterations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study Alvarez, Ricardo H.; Garrett-Mayer, Elizabeth; Halabi, Susan; Mangat, Pam K.; Al Baghdadi, Tareq; Ahn, Eugene R.; Chai, Seungjean; Rygiel, Andrew L.; Antonelli, Kaitlyn R.; Islam, Samiha; Bruinooge, Suanna S.; Schilsky, Richard L. 分享 收藏
Clinicopathologic characterization and comprehensive genomic profiling (CGP) of advanced breast cancer patients with fibroblast growth factor receptor (FGFR) alterations Alvarez, R. H.; Thomas, J. W.; Kramer, K.; Niu, J.; Ahn, E.; McKnight, J. E.; Dhillon, N.; Pabbathi, H.; Johnson, A. T.; Wang, K.; Ross, J. S.; Miller, V. A.; Stephens, P. J.; Daneker, G. W.; Ali, S.; Markman, M. 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
.png){kind=icon}
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
